3
2
1

Cutting-Edge Medical Innovations: 3D Bioprinting, Making Bone and Soft Tissue 'Rebirth' No Longer a Dream

Release time:

2024-09-12

Recently, good news came from the Hefei Institutes of Physical Science, Chinese Academy of Sciences. The research team led by researcher Wang Junfeng successfully developed an innovative 3D bioprinting composite material that has shown great potential in repairing damaged tissues. Their research has been published in internationally renowned journals.

Imagine if you had a bone or soft tissue injury, now there is a magical material that can help it recover faster and better. This new type of biological boron-based glass (BBG) composite material does just that. BBG is already a popular bioactive material in the medical field, particularly beneficial for bone repair and regeneration. Now, Wang Junfeng's team has cleverly utilized BBG, combined with advanced 3D printing technology, to create more customized and efficient repair solutions.

In the field of bone repair, the team designed a special composite material containing various proportions of BBG. Using a technique called selective laser sintering, similar to laser engraving, they precisely printed scaffolds suitable for bone defects. These scaffolds are not only structurally strong but also very conducive to cell growth, accelerating the bone regeneration process. Results showed that with the addition of BBG, the overall performance of the scaffolds improved significantly. For example, the porosity allows cells to grow more easily, the mechanical strength ensures scaffold stability, and its hydrophilicity and degradation rate are just right, making it very suitable for human environments.

For soft tissue repair, the team took a different approach by mixing BBG particles with sodium alginate to create a high-precision 3D printed bio-ink. The scaffolds printed with this ink have a smooth printing process and minimal shrinkage after forming, making them ideal for repairing soft tissues like skin and muscles. More importantly, the combination of BBG and sodium alginate can promote cell adhesion and proliferation, helping soft tissues recover healthily and quickly.

Overall, the new type of 3D bioprinting composite material developed by Wang Junfeng's team shows great potential for both bone repair and soft tissue regeneration. In the future, this material is expected to bring more breakthroughs to the medical field and help more patients regain their health.

Latest developments

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.